Results 181 to 190 of about 86,128 (305)

Estimation of the Weibull Distribution Parameters and Reliability Using Runge-Kutta Method based on Interval-Censored Data

, 2023
Maswadah M.
europepmc   +1 more source

Gompertz model with time-dependent covariate in the presence of interval-, right- and left-censored data

, 2012
Kaveh Kiani, Jayanthi Arasan
openalex   +2 more sources

Denosumab Offers Relatively Lower Initial Protection Against Osteoporotic Vertebral Fractures in Treatment‐Naive Patients Compared With Zoledronate

Clinical Pharmacology &Therapeutics, EarlyView.
We compared the initial efficacy of denosumab (Dmab) and zoledronate (ZOL) in treatment‐naive patients with osteoporosis. This cohort study, based on TriNetX data, evaluated the risks of fractures and mortality using Kaplan–Meier survival analyses, with hazard ratios (HRs) and 95% confidence intervals (CIs).
Ko‐Hsiu Lu, Shiow‐Ing Wang, Shun‐Fa Yang   +2 more
wiley   +1 more source

Likelihood-Based Inference for Semi-Parametric Transformation Cure Models with Interval Censored Data. [PDF]

Commun Stat Simul Comput
Pal S, Barui S.
europepmc   +1 more source

A Bayesian approach for analyzing partly interval-censored data under the proportional hazards model. [PDF]

Stat Methods Med Res, 2020
Pan C, Cai B, Wang L.
europepmc   +1 more source

Regression analysis of interval-censored competing risks data with missing causes of failure: A direct likelihood approach

Yichen Lou, Yuqing Ma, Liming Xiang, Jianguo Sun   +3 more
openalex   +1 more source

Cardiorenal Outcomes of Dapagliflozin vs. Empagliflozin in Advanced Chronic Kidney Disease and Diabetes

Clinical Pharmacology &Therapeutics, EarlyView.
Target trial emulation of a multi‐institutional electronic health record network showed comparable cardiorenal effectiveness and safety of dapagliflozin versus empagliflozin in adults with type 2 diabetes and advanced‐stage chronic kidney disease.
Shih‐Hsuan Lin, Jia‐Jin Chen, Ching‐Chung Hsiao, Yu‐Wei Fang, Meng‐Ting Chen, Ming‐Hsien Tsai, Huang‐Yu Yang   +6 more
wiley   +1 more source

Likelihood Inference for Unified Transformation Cure Model with Interval Censored Data. [PDF]

Comput Stat
Treszoks J, Pal S.
europepmc   +1 more source

Closed-Form Solutions for the Weibull Distribution Parameters and Performance Lifetime Index with Interval-Censored Data

Zhengcheng Mou, Yi Li, Jyun‐You Chiang, Tzong-Ru Tsai   +3 more
openalex   +1 more source

QUANTILE REGRESSION MODELS FOR INTERVAL-CENSORED FAILURE TIME DATA

, 2019
Fang‐Shu Ou
openalex   +2 more sources